Center-Authored Papers

Filters: Author is Delaney, Colleen  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Young Adult
Gutman JA, Leisenring WM, Appelbaum FR, Woolfrey AE, Delaney C.  2009.  Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(9):1122-9. Abstract
Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID.  2010.  Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.. Nature medicine. 16(2):232-6. Abstract
Milano F, Pergam SA, Xie H, Leisenring WM, Gutman JA, Riffkin I, Chow V, Boeckh MJ, Delaney C.  2011.  Intensive strategy to prevent cytomegalovirus disease in seropositive umbilical cord blood transplant recipients.. Blood. 118(20):5689-96. Abstract
Brunstein CG, Gutman JA, Weisdorf DJ, Woolfrey AE, Defor TE, Gooley TA, Verneris MR, Appelbaum FR, Wagner JE, Delaney C.  2010.  Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.. Blood. 116(22):4693-9. Abstract
Zerr DM, Fann JR, Breiger D, Boeckh MJ, Adler AL, Xie H, Delaney C, Huang M-L, Corey L, Leisenring WM.  2011.  HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients.. Blood. 117(19):5243-9. Abstract
Gutman JA, Turtle CJ, Manley TJ, Heimfeld S, Bernstein ID, Riddell SR, Delaney C.  2010.  Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.. Blood. 115(4):757-65. Abstract
Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, Witherspoon R, Mielcarek M, Deeg HJ, Sorror M et al..  2016.  Cord-Blood Transplantation in Patients with Minimal Residual Disease.. The New England journal of medicine. 375(10):944-53. Abstract
Gutman JA, McKinney SK, Pereira S, Warnock SL, Smith AG, Woolfrey AE, Hansen JA, Delaney C.  2009.  Prospective monitoring for alloimmunization in cord blood transplantation: "virtual crossmatch" can be used to demonstrate donor-directed antibodies.. Transplantation. 87(3):415-8. Abstract
Whole-Body Irradiation
Delaney C, Gutman JA, Appelbaum FR.  2009.  Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications.. British journal of haematology. 147(2):207-16. Abstract
Virus Activation
Zerr DM, Fann JR, Breiger D, Boeckh MJ, Adler AL, Xie H, Delaney C, Huang M-L, Corey L, Leisenring WM.  2011.  HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients.. Blood. 117(19):5243-9. Abstract
Viral Load
Milano F, Pergam SA, Xie H, Leisenring WM, Gutman JA, Riffkin I, Chow V, Boeckh MJ, Delaney C.  2011.  Intensive strategy to prevent cytomegalovirus disease in seropositive umbilical cord blood transplant recipients.. Blood. 118(20):5689-96. Abstract
Vidarabine
Burroughs LM, Nemecek ER, Torgerson TR, Storer BE, Talano J-A, Domm J, Giller RH, Shimamura A, Delaney C, Skoda-Smith S et al..  2014.  Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(12):1996-2003. Abstract
Vaccine and Infectious Disease Division
Milano F, Pergam SA, Xie H, Leisenring WM, Gutman JA, Riffkin I, Chow V, Boeckh MJ, Delaney C.  2011.  Intensive strategy to prevent cytomegalovirus disease in seropositive umbilical cord blood transplant recipients.. Blood. 118(20):5689-96. Abstract
Milano F, Chien JW, Riffkin I, Gutman JA, Newell L, Pergam SA, Delaney C.  2012.  Stable Long-Term Pulmonary Function After Myeloablative Double Cord Blood Transplant.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(2):309-313. Abstract
Zerr DM, Fann JR, Breiger D, Boeckh MJ, Adler AL, Xie H, Delaney C, Huang M-L, Corey L, Leisenring WM.  2011.  HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients.. Blood. 117(19):5243-9. Abstract
Zerr DM, Boeckh MJ, Delaney C, Martin PJ, Xie H, Adler AL, Huang M-L, Corey L, Leisenring WM.  2012.  HHV-6 Reactivation and Associated Sequelae after Hematopoietic Cell Transplant.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(11):1700-1708. Abstract
Unrelated Donors
Burroughs LM, Nemecek ER, Torgerson TR, Storer BE, Talano J-A, Domm J, Giller RH, Shimamura A, Delaney C, Skoda-Smith S et al..  2014.  Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(12):1996-2003. Abstract
Umbilical Cord
Brunstein CG, Gutman JA, Weisdorf DJ, Woolfrey AE, Defor TE, Gooley TA, Verneris MR, Appelbaum FR, Wagner JE, Delaney C.  2010.  Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.. Blood. 116(22):4693-9. Abstract
Treatment Outcome
Gutman JA, McKinney SK, Pereira S, Warnock SL, Smith AG, Woolfrey AE, Hansen JA, Delaney C.  2009.  Prospective monitoring for alloimmunization in cord blood transplantation: "virtual crossmatch" can be used to demonstrate donor-directed antibodies.. Transplantation. 87(3):415-8. Abstract
Treatment Failure
Gutman JA, McKinney SK, Pereira S, Warnock SL, Smith AG, Woolfrey AE, Hansen JA, Delaney C.  2009.  Prospective monitoring for alloimmunization in cord blood transplantation: "virtual crossmatch" can be used to demonstrate donor-directed antibodies.. Transplantation. 87(3):415-8. Abstract
Transplantation, Homologous
Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, Witherspoon R, Mielcarek M, Deeg HJ, Sorror M et al..  2016.  Cord-Blood Transplantation in Patients with Minimal Residual Disease.. The New England journal of medicine. 375(10):944-53. Abstract
Brunstein CG, Gutman JA, Weisdorf DJ, Woolfrey AE, Defor TE, Gooley TA, Verneris MR, Appelbaum FR, Wagner JE, Delaney C.  2010.  Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.. Blood. 116(22):4693-9. Abstract
Milano F, Appelbaum FR, Delaney C.  2016.  Cord-Blood Transplantation in Patients with Minimal Residual Disease-Reply to Gupta, Hourigan, et al.. The New England journal of medicine. 375(22):2204-2205.
Transplantation Conditioning
Gutman JA, Turtle CJ, Manley TJ, Heimfeld S, Bernstein ID, Riddell SR, Delaney C.  2010.  Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.. Blood. 115(4):757-65. Abstract
Milano F, Appelbaum FR, Delaney C.  2016.  Cord-Blood Transplantation in Patients with Minimal Residual Disease-Reply to Gupta, Hourigan, et al.. The New England journal of medicine. 375(22):2204-2205.